Article
A translational transcriptomic signature of vaccine reactogenicity for the evaluation of novel formulations
2025-11-25
Abstract excerpt
<h4>ABSTRACT</h4> Accurately predicting vaccine reactogenicity at the preclinical stage remains a major challenge in vaccine development, as conventional animal studies and in vitro assays capture general inflammation but fail to quantify local or systemic reactogenicity relevant to humans. Using transcriptomic data from the BioVacSafe consortium encompassing seven vaccines and immunostimulants in mice and five l...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- ed283baa-6eca-52ae-a005-0256d3aa8796
- DOI
- 10.1101/2025.11.20.689650
